Opportunity Information: Apply for PAR 23 113
The NINDS Institutional AD/ADRD Research Training Program (T32 Clinical Trial Not Allowed), funding opportunity PAR-23-113, is an NIH discretionary grant designed to support university- and institution-based research training programs focused on Alzheimers disease and Alzheimers disease-related dementias (AD/ADRD). The central goal is workforce development: helping institutions train neuroscientists who finish the program with the research skills, scientific grounding, and professional development needed to make meaningful contributions to understanding and addressing cognitive impairment and dementia tied to AD/ADRD.
A key emphasis of this opportunity is building training programs that cover the full range of AD/ADRD research areas rather than focusing narrowly on a single diagnosis. Programs are expected to broaden and deepen trainee exposure across the spectrum, which may include Alzheimers disease itself as well as vascular contributions to cognitive impairment and dementia (VCID), Lewy body dementia (LBD), frontotemporal dementia (FTD), and mixed dementias. The FOA encourages programs that integrate structured coursework or didactic activities, hands-on mentored research experiences, and career development elements under a coherent AD/ADRD theme. The research supported through the training environment can be basic, clinical, and/or translational, but the announcement explicitly states that clinical trials are not allowed under this T32 training mechanism.
From a training-content standpoint, NINDS is looking for programs with formal, intentional instruction that goes beyond lab apprenticeship. Supported programs must include components that ensure trainees gain a solid understanding of experimental design, statistical principles, and methodological approaches relevant to modern dementia research. They also must strengthen analytical skills and scientific communication skills, both written and oral, with the expectation that trainees can explain their work to diverse audiences (for example, scientific peers, clinicians, community stakeholders, and other non-specialists). Another required theme is quantitative literacy: programs are expected to create or provide opportunities that help trainees apply quantitative approaches in their research, reflecting how central data-driven methods are to AD/ADRD science (e.g., rigorous statistics, computational methods, and other analytical frameworks appropriate to the trainee projects).
The training experience is intended to be two years in duration and is aimed at trainees who are already positioned to benefit from focused research training. The FOA supports one or more of the following groups: dissertation-stage predoctoral students in their third and/or fourth year of graduate school, postdoctoral fellows, and fellowship-stage clinicians. Notably, NINDS does not support first- or second-year graduate students under this specific announcement, so programs need to be structured around trainees at later predoctoral stages or beyond.
Eligibility is broad across many types of U.S.-based institutions and organizations. Eligible applicants include state, county, city, township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized tribal governments; tribal organizations that are not federally recognized; public housing authorities/Indian housing authorities; nonprofits with and without 501(c)(3) status (excluding institutions of higher education when applicable); for-profit organizations other than small businesses; small businesses; and other organizations that meet NIH eligibility rules. The FOA also explicitly highlights additional eligible applicant categories such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISI), as well as faith-based or community-based organizations, eligible federal agencies, regional organizations, and U.S. territories or possessions. At the same time, it clearly restricts foreign involvement on the applicant side: non-domestic (non-U.S.) entities and foreign institutions are not eligible to apply, and non-domestic components of U.S. organizations are also not eligible.
Administratively, this is an NIH grant (Funding Instrument: Grant) in the health category, associated with CFDA numbers 93.853 and 93.866, and run through the National Institutes of Health with NINDS as the sponsoring institute. The posting lists an original closing date of 2024-05-25 and a creation date of 2023-03-20. The award ceiling and expected number of awards are not specified in the provided source data, meaning prospective applicants typically need to consult the full FOA and NIH budgeting guidance for allowable costs and program size expectations. Overall, the opportunity is best understood as a structured, institution-led training platform meant to produce highly capable AD/ADRD researchers with strong quantitative and methodological foundations, clear communication skills, and the readiness to advance dementia research across multiple disease domains.Apply for PAR 23 113
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "NINDS Institutional AD/ADRD Research Training Program (T32 Clinical Trial Not Allowed)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.853, 93.866.
- This funding opportunity was created on 2023-03-20.
- Applicants must submit their applications by 2024-05-25. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Health
Next opportunity: BJA FY 23 Paul Coverdell Forensic Science Improvement Grants Program - Formula
Previous opportunity: NIA Expanding Research in AD/ADRD (ERA) Summer Research Education Program (R25 - Independent Clinical Trial Not Allowed)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 23 113
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 23 113) also looked into and applied for these:
| Funding Opportunity |
|---|
| Limited Competition: Molecular Transducers of Physical Activity Chemical Analysis Sites (U24 Clinical Trial Not Allowed) Apply for RFA RM 23 009 Funding Number: RFA RM 23 009 Agency: National Institutes of Health Category: Health Funding Amount: $350,000 |
| Limited Competition: Molecular Transducers of Physical Activity Bioinformatics Center (U24 Clinical Trial Not Allowed) Apply for RFA RM 23 008 Funding Number: RFA RM 23 008 Agency: National Institutes of Health Category: Health Funding Amount: $1,500,000 |
| Limited Competition: Molecular Transducers of Physical Activity Consortium Coordinating Center (U24 Clinical Trial Not Allowed) Apply for RFA RM 23 011 Funding Number: RFA RM 23 011 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition: Molecular Transducers of Physical Activity Clinical Centers (U01 Clinical Trial Required) Apply for RFA RM 23 010 Funding Number: RFA RM 23 010 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Defining Mechanisms of HIV Induced Inflammation and Immune Activation During Suppressive Antiretroviral Therapy (ART) (R01 Clinical Trial Not Allowed) Apply for RFA AI 23 018 Funding Number: RFA AI 23 018 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Integration and Coordination Center for the Common Fund Data Ecosystem (U54 Clinical Trial Not Allowed) Apply for RFA RM 23 002 Funding Number: RFA RM 23 002 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIH Directors Transformative Research Awards (R01 Clinical Trial Optional) Apply for RFA RM 23 006 Funding Number: RFA RM 23 006 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Suicide Prevention Across the Life Span in Low- and Middle-Income Countries (R34 Clinical Trial Optional) Apply for RFA MH 23 260 Funding Number: RFA MH 23 260 Agency: National Institutes of Health Category: Health Funding Amount: $450,000 |
| NIH Directors Early Independence Awards (DP5 Clinical Trial Optional) Apply for RFA RM 23 007 Funding Number: RFA RM 23 007 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Understanding Neurological Effects of COVID-19 and Post-Acute Sequelae of SARS-CoV-2 Infection (R01 Clinical Trial Optional) Apply for RFA NS 23 021 Funding Number: RFA NS 23 021 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| NIH Directors New Innovator Award Program (DP2 Clinical Trial Optional) Apply for RFA RM 23 005 Funding Number: RFA RM 23 005 Agency: National Institutes of Health Category: Health Funding Amount: $900,000 |
| NIDCR Small Research Grants for Analyses of Existing Genomics Data (R03 Clinical Trial Not Allowed) Apply for PAR 23 132 Funding Number: PAR 23 132 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Animal Models for Hepatitis B and C (R01 Clinical Trial Not Allowed) Apply for RFA AI 23 022 Funding Number: RFA AI 23 022 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIDCR Research Grants for Analyses of Existing Genomics Data (R01) (Clinical Trial Not Allowed) Apply for PAR 23 133 Funding Number: PAR 23 133 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Understanding Neurological Effects of COVID-19 and Post-Acute Sequelae of SARS-CoV-2 Infection (R21 Clinical Trial Optional) Apply for RFA NS 23 022 Funding Number: RFA NS 23 022 Agency: National Institutes of Health Category: Health Funding Amount: $275,000 |
| Pulmonary Outcomes and Sequelae after Treatment-TB (POST-TB) (R01 Clinical Trial Optional) Apply for PAR 23 148 Funding Number: PAR 23 148 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Developing Measures to Advance Access and Quality in Global Mental Health Services (R34 Clinical Trial Not Allowed) Apply for RFA MH 23 300 Funding Number: RFA MH 23 300 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Implementing and Evaluating New Models for Delivering Comprehensive, Coordinated, Person-Centered Care to People with Long COVID (U18) Apply for RFA HS 23 012 Funding Number: RFA HS 23 012 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Collaborative Research Centers (CRCs) (U54 Clinical Trial Optional) Apply for RFA NS 24 022 Funding Number: RFA NS 24 022 Agency: National Institutes of Health Category: Health Funding Amount: $1,200,000 |
| Limited Competition: NEI - DOD Vision Research Collaborative (R01 Clinical Trial Optional) Apply for PAR 23 141 Funding Number: PAR 23 141 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 23 113", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.